[Credit Update] Perennial Holdings: Strong Healthcare-Led Growth Amid Tight Debt Servicing Capacity

 |   08 May 2026  |    8 views

Company at a Glance

What the company does:
Perennial Holdings (PREHSP) is a Singapore-based real estate and healthcare platform with operations across China, Singapore, Malaysia, and Ghana, with China remaining its core market. The group combines property ownership, development, and healthcare operations, positioning itself to capture both asset value and long-term healthcare demand. Its shareholder base includes Kuok Khoon Hong (29%), Wilmar International (16%), Hopu Investments (14%), Perpetual Capital (11%), Ron Sim (13%), Bangkok Bank (9%), and Pua Seck Guan (8%).


Main income source:
PREHSP’s revenue increased from S$287.7mn in FY2024 to S$384.6mn in FY2025 (+33% YoY), driven mainly by the healthcare segment, which contributed approximately 56% of total revenue. Around 60% of healthcare revenue comes from partnership-based models, in which the group collaborates with doctors and earns a combination of fees and profit-sharing.


What Supports the Credit Profile

Factsheets


The group owns a sizeable asset base, including key Singapore assets such as CHIJMES, Capitol Singapore and Golden Mile valued at ~S$4.8bn, alongside China healthcare developments in Tianjin, Chengdu, Kunming and Xi’an at ~RMB56bn. These assets can monetised if required. Management has guided ongoing capital recycling initiatives, including a China C-REIT spin-off (target Sep 2026) and the potential disposal of Capitol Singapore.

From a growth perspective, PREHSP is exposed to a high-demand yet underpenetrated private healthcare market, with only ~0.9% of patients currently using private healthcare despite ~47% of the population being able to afford it (based on management data). The group has a visible pipeline (~88%) concentrated in Tier 1 and quasi-Tier 1 cities such as Tianjin, Chengdu and Kunming, with total capacity expected to exceed ~37,000 beds. Its doctor partnership model, together with proven execution (e.g. Chengdu achieving breakeven within ~12 months), supports faster ramp-up and utilisation.


Main Areas to Monitor:

EBITDA declined sharply to S$47.5mn (vs S$223.6mn in FY2024), mainly due to the absence of fair value gains, and remains below FY2023 levels (S$146.8mn), where earnings were similarly supported by such gains. This suggests that the underlying operating performance is still in the ramp-up phase. Management has guided that Tianjin is expected to reach breakeven in 2026, which should support further earnings growth.

Credit metrics remain weak. Approximately S$1.29bn of debt is maturing in 2026, with leverage rising (debt/assets: 0.38x to 0.41x; net debt/equity: 0.71x to 0.83x). Interest coverage declined sharply from 1.10x to 0.09x, highlighting weak debt servicing capacity and continued reliance on refinancing and asset monetisation.


Financial Position

Factsheets


PREHSP SGD Bond Opportunities

Factsheets


Our Credit View

We are neutral on PREHSP’s credit profile, supported by strong structural demand, a visible Tier 1 pipeline, and demonstrated execution (e.g. Chengdu breakeven within ~12 months; Tianjin expected breakeven in 2026). The group also benefits from a sizeable asset base (~S$4.8bn in Singapore; ~RMB56bn in China), which provides monetisation flexibility. Management is actively executing capital recycling initiatives, including a China C-REIT (target Sep 2026) and asset divestments (e.g. Capitol Singapore). However, the credit profile remains constrained by it sharply deteriorated interest coverage of ~0.09x in FY2025.


Related Articles

[Credit Update] Global Resource Construction Ltd (GRC Group): Scale Expansion Through Acquisition with Visible Order Book Support

Global Resource Construction Ltd. is a Singapore-based, construction-led group spanning building construction, civil infrastructure, environmental engineering, prefabrication and procurement.

 |   08 May 2026

[Equity Report] Thakral Corporation Ltd – Multiple Levers for Growth

 2H25/FY25 PATMI surged 242%/493% YoY to S$61.6mn/S$170.9mn, exceeding our expectations and reaching 53%/146% of our FY25e forecast.

 |   13 Mar 2026

Thakral Corporation Ltd – Improving earnings visibility supports credit profile

Thakral Corporation Ltd has been listed on the SGX Mainboard since December 1995. The Group’s core business comprises a growing investment portfolio in Australia, Japan, and Singapore.

 |   12 Mar 2026

Disclaimers


These commentaries are intended for general circulation. It does not have regard to the specific investment objectives, financial situation and particular needs of any person who may receive this document. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of the units and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. Investors may wish to seek advice from a financial adviser before investing. In the event that investors choose not to seek advice from a financial adviser, they should consider whether the investment is suitable for them.

The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the "Research") contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries.

Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned.

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com

?>